HIGHLIGHTS
- who: Tal Zivan and collaborators from the Department of Medicine, Thomas Jefferson University Hospital, S, th St, Philadelphia, PA, USA have published the research: Safety of Adenosine for the Treatment of Supraventricular Tachycardia in Hospitalized Patients with COVID-19 Pneumonia, in the Journal: (JOURNAL)
- what: The study has several limitations inherent to a relatively small retrospective analysis. The authors report on a relatively small number of patients.
- how: The authors compared a study group of 42 COVID-19 hospitalized patients who received adenosine for SVT to a matched (for age sex and co . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.